Board Stats

Navidea Biopharmaceuticals, Inc.

Y! IH NAVB EXPRESS NAVB Advanced Due Diligence NAVB Oldtimers Lounge

NAVB / Message Board

BOARD

GROUPS

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
27257	Re: 2017: "tumor-associated macrophages (TAMs) have become a significant attraction for researchers".."Tumor-associated macrophages, nanomedicine and imaging: The axis of success in the future of cancer immunotherapy"	GN	dwdinvesting		1	9/22/2018 10:36:00 PM

27256	2017: "tumor-associated macrophages (TAMs) have become a significant attraction for researchers".."Tumor-associated macrophages, nanomedicine and imaging: The axis of success in the future of cancer immunotherapy"	GN	moneyonomics		2	9/22/2018 8:04:49 PM

27255	Originally posted on 04/20/2018: Re: 3D Imaging of Liver in NASH: “You’re looking at the Holy Grail of Medicine. . .once those images become available, a partnership would be imminent."--Jed Latkin	GN	dwdinvesting		0	9/22/2018 2:36:29 PM

27254	Re: Navidea I/D...15 month Gantt Plan...Activity 1---Link to timeline?	GN	deut8:18		5	9/22/2018 6:05:33 AM

27253	Closed up 3% on a Friday	GN	dwdinvesting		0	9/21/2018 4:03:46 PM

27252	Re: Gottlieb: FDA pursuing faster approval path for diagnostics	GN	oxymoron_alert		0	9/21/2018 3:05:18 PM

27251	Re: Gottlieb: FDA pursuing faster approval path for diagnostics	GN	dwdinvesting		0	9/21/2018 2:27:04 PM

27250	Re: Gottlieb: FDA pursuing faster approval path for diagnostics	GN	moneyonomics		3	9/21/2018 2:24:06 PM

27249	Re: Gottlieb: FDA pursuing faster approval path for diagnostics	GN	Fall1980		7	9/21/2018 1:39:45 PM

27248	Re: Gottlieb: FDA pursuing faster approval path for diagnostics	GN	Jacobsbets		3	9/21/2018 12:34:01 AM

Go to Msg #

BOARDS Sign In for Filters